MedPath
FDA Approval

Tavaborole

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
April 12, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tavaborole(43.5 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Zydus Lifesciences Limited

Zydus Lifesciences Limited

650650802

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tavaborole

Product Details

NDC Product Code
70771-1826
Application Number
ANDA212294
Marketing Category
ANDA (C73584)
Route of Administration
TOPICAL
Effective Date
April 12, 2023
Code: K124A4EUQ3Class: ACTIBQuantity: 43.5 mg in 1 mL
EDETATE CALCIUM DISODIUMInactive
Code: 25IH6R4SGFClass: IACT
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
© Copyright 2025. All Rights Reserved by MedPath